AAAAAAHHHHHH!!!!! It’s the news we’ve all been waiting for!!! FDA will review the Pfizer vaccine for kids ages 5-11 on October 26!!
On October 1st, the FDA announced that it “anticipates receiving a request from Pfizer to amend its emergency use authorization to allow the use of its COVID-19 vaccine in children 5 through 11 years of age.”
Looking to minimize delays, FDA has pre-scheduled a meeting of its independent advisory committee on vaccines for Oct 26. The committee of the United States’ leading experts on vaccines will review the data and *could* recommend extending the EUA down to age 5 at that meeting.
This meeting could end up delayed if Pfizer doesn’t get the data to the FDA in time for review, but we sure hope not! Keep up to date by following U.S. Food and Drug Administration on Facebook or Twitter, or by checking the advisory committee meeting calendar.
On the 26th, we’ll be able to watch the meeting here.
You know #thosenerdygirls will be watching! And we’ll definitely update you!
Here’s the FDA announcement.
ps. FDA’s advisory committee on vaccines will also meet on Oct 14 and 15 to talk about booster shots for Moderna and J&J vaccines and mix-and-match boosters. Oh yes!
pps. No word yet on the expected date for data on even younger children’s vaccines.